Articles related to Hepatology

For patients with cirrhosis facing venous thromboembolic events, the choice of anticoagulant—be it DOACs or LMWH—demands careful consideration of their unique hemostatic profile, emphasizing the need for personalized treatment strategies.

In this Phase 3 trial, resmetirom demonstrated a notable capacity to induce NASH resolution and improve liver fibrosis, offering hope for a therapeutic breakthrough in a field with limited treatment options. This study emphasizes the importance of advancing research in liver-directed therapies for NASH.

Explore innovative options for patients with pancreas, liver and biliary cancers at the Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2023.

The rise in Vibrio bacteria infections, linked to increasing ocean temperatures, is a stark reminder of why we need to pay attention to the changing landscape of infectious diseases. With as many as one in five people with this infection dying, sometimes within days, it’s clear that this is a public health issue that warrants our attention.

Explore how prioritizing gut health may offer a head start advantage in combating neurodegenerative diseases.

Discover how STRIDE is setting new benchmarks in the treatment of unresectable hepatocellular carcinoma, offering both improved survival rates and a tolerable safety profile.